The market opportunity Savers SVV is chasing Volatility Increases 20260508 LBRX LB Pharmaceuticals posts slightly smaller Q4 2025 loss than analyst estimates shares rise 366 percent What Archimedes ATIIW management focus reveals about priorities Overhead Buying 20260508 ESPR Esperion Therapeutics reports Q4 2025 EPS miss shares post small gains even as earnings lag analyst estimates